Its a pity there wasn't a spike globally in the amount of people suffering IIH which seemed to be growing. The FDA wouldn't give a toss about the study end point, just run one and they'd approve it
Ann: Invex Receives Written Response from FDA on Type C Meeting, page-11
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29099 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 72051 | 2 |
View Market Depth
| Last trade - 11.04am 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable